Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS)
CNY 29.78
(0.51%)
CNY 29.78
(0.51%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 9.65 Billion CNY | 5.69% |
| 2022 | 8.99 Billion CNY | 17.9% |
| 2021 | 7.63 Billion CNY | 23.77% |
| 2020 | 6.16 Billion CNY | -11.17% |
| 2019 | 6.93 Billion CNY | -3.72% |
| 2018 | 7.2 Billion CNY | 27.76% |
| 2017 | 5.64 Billion CNY | 20.61% |
| 2016 | 4.67 Billion CNY | 24.15% |
| 2015 | 3.76 Billion CNY | 26.17% |
| 2014 | 2.98 Billion CNY | 22.02% |
| 2013 | 2.44 Billion CNY | 1429.54% |
| 2012 | 160.02 Million CNY | -33.45% |
| 2011 | 240.46 Million CNY | 1.4% |
| 2010 | 237.14 Million CNY | 6.81% |
| 2009 | 222.01 Million CNY | 4.24% |
| 2008 | 212.98 Million CNY | -2.55% |
| 2007 | 218.55 Million CNY | 8.89% |
| 2006 | 200.71 Million CNY | 13.94% |
| 2005 | 176.15 Million CNY | 20.54% |
| 2004 | 146.14 Million CNY | 28.84% |
| 2003 | 113.42 Million CNY | 5.72% |
| 2002 | 107.29 Million CNY | -5.85% |
| 2001 | 113.96 Million CNY | 16.5% |
| 2000 | 97.81 Million CNY | 19.37% |
| 1999 | 81.94 Million CNY | 25.93% |
| 1998 | 65.06 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.6 Billion CNY | -32.02% |
| 2024 Q1 | 2.36 Billion CNY | -23.03% |
| 2024 Q3 | 1.77 Billion CNY | 10.19% |
| 2023 Q1 | 2.38 Billion CNY | -23.03% |
| 2023 FY | 9.5 Billion CNY | 5.69% |
| 2023 Q4 | 3.07 Billion CNY | 60.98% |
| 2023 Q3 | 1.9 Billion CNY | -14.86% |
| 2023 Q2 | 2.24 Billion CNY | -6.18% |
| 2022 Q4 | 3.1 Billion CNY | 52.8% |
| 2022 Q2 | 1.68 Billion CNY | -22.28% |
| 2022 Q1 | 2.17 Billion CNY | -2.15% |
| 2022 FY | 8.99 Billion CNY | 17.9% |
| 2022 Q3 | 2.03 Billion CNY | 20.19% |
| 2021 Q2 | 1.76 Billion CNY | -7.85% |
| 2021 Q1 | 1.91 Billion CNY | 3.52% |
| 2021 Q4 | 2.22 Billion CNY | 28.64% |
| 2021 Q3 | 1.72 Billion CNY | -2.21% |
| 2021 FY | 7.63 Billion CNY | 23.77% |
| 2020 Q4 | 1.85 Billion CNY | 35.84% |
| 2020 FY | 6.16 Billion CNY | -11.17% |
| 2020 Q2 | 943.55 Million CNY | -53.0% |
| 2020 Q3 | 1.36 Billion CNY | 44.42% |
| 2020 Q1 | 2 Billion CNY | 29.2% |
| 2019 Q4 | 1.55 Billion CNY | 5.07% |
| 2019 Q1 | 2.07 Billion CNY | 24.95% |
| 2019 Q2 | 1.82 Billion CNY | -12.11% |
| 2019 Q3 | 1.47 Billion CNY | -19.07% |
| 2019 FY | 6.93 Billion CNY | -3.72% |
| 2018 Q2 | 1.67 Billion CNY | -21.22% |
| 2018 Q4 | 1.66 Billion CNY | -4.37% |
| 2018 FY | 7.2 Billion CNY | 27.76% |
| 2018 Q1 | 2.12 Billion CNY | 48.95% |
| 2018 Q3 | 1.74 Billion CNY | 3.83% |
| 2017 Q2 | 1.4 Billion CNY | 0.04% |
| 2017 Q1 | 1.4 Billion CNY | 19.92% |
| 2017 FY | 5.64 Billion CNY | 20.61% |
| 2017 Q4 | 1.42 Billion CNY | 1.78% |
| 2017 Q3 | 1.4 Billion CNY | -0.14% |
| 2016 Q4 | 1.17 Billion CNY | 1.63% |
| 2016 FY | 4.67 Billion CNY | 24.15% |
| 2016 Q1 | 1.15 Billion CNY | 21.57% |
| 2016 Q3 | 1.15 Billion CNY | -3.72% |
| 2016 Q2 | 1.19 Billion CNY | 3.51% |
| 2015 Q4 | 951.37 Million CNY | 0.81% |
| 2015 FY | 3.76 Billion CNY | 26.17% |
| 2015 Q2 | 968.25 Million CNY | 7.05% |
| 2015 Q3 | 943.74 Million CNY | -2.53% |
| 2015 Q1 | 904.46 Million CNY | 17.67% |
| 2014 Q2 | 754.49 Million CNY | 5.83% |
| 2014 Q3 | 750.29 Million CNY | -0.56% |
| 2014 Q4 | 768.66 Million CNY | 2.45% |
| 2014 FY | 2.98 Billion CNY | 22.02% |
| 2014 Q1 | 712.95 Million CNY | -69.1% |
| 2013 Q4 | 2.3 Billion CNY | 6218.19% |
| 2013 FY | 2.44 Billion CNY | 1429.54% |
| 2013 Q2 | 37.72 Million CNY | -43.0% |
| 2013 Q1 | 66.18 Million CNY | 431.22% |
| 2013 Q3 | 36.51 Million CNY | -3.21% |
| 2012 Q3 | 57.79 Million CNY | 1.17% |
| 2012 Q1 | 65.08 Million CNY | 29.03% |
| 2012 Q2 | 57.12 Million CNY | -12.22% |
| 2012 FY | 160.02 Million CNY | -33.45% |
| 2012 Q4 | -19.98 Million CNY | -134.58% |
| 2011 FY | 240.46 Million CNY | 1.4% |
| 2011 Q1 | 49.93 Million CNY | -32.58% |
| 2011 Q2 | 71.17 Million CNY | 42.53% |
| 2011 Q3 | 68.92 Million CNY | -3.16% |
| 2011 Q4 | 50.43 Million CNY | -26.82% |
| 2010 Q2 | 63.64 Million CNY | 47.17% |
| 2010 FY | 237.14 Million CNY | 6.81% |
| 2010 Q4 | 74.06 Million CNY | 31.84% |
| 2010 Q3 | 56.18 Million CNY | -11.73% |
| 2010 Q1 | 43.24 Million CNY | -40.9% |
| 2009 Q1 | 39.57 Million CNY | -40.66% |
| 2009 FY | 222.01 Million CNY | 4.24% |
| 2009 Q4 | 73.18 Million CNY | 32.84% |
| 2009 Q3 | 55.08 Million CNY | 1.69% |
| 2009 Q2 | 54.17 Million CNY | 36.87% |
| 2008 Q1 | 38.3 Million CNY | -45.07% |
| 2008 Q3 | 50.97 Million CNY | -10.58% |
| 2008 FY | 212.98 Million CNY | -2.55% |
| 2008 Q4 | 66.69 Million CNY | 30.83% |
| 2008 Q2 | 57 Million CNY | 48.81% |
| 2007 Q3 | 51.27 Million CNY | -16.23% |
| 2007 Q2 | 61.21 Million CNY | 68.56% |
| 2007 Q1 | 36.31 Million CNY | -44.93% |
| 2007 FY | 218.55 Million CNY | 8.89% |
| 2007 Q4 | 69.74 Million CNY | 36.01% |
| 2006 Q4 | 65.94 Million CNY | 48.72% |
| 2006 Q2 | 53.65 Million CNY | 45.89% |
| 2006 Q1 | 36.77 Million CNY | -22.8% |
| 2006 Q3 | 44.34 Million CNY | -17.35% |
| 2006 FY | 200.71 Million CNY | 13.94% |
| 2005 Q2 | 55.19 Million CNY | 57.46% |
| 2005 Q4 | 47.63 Million CNY | 24.49% |
| 2005 Q3 | 38.26 Million CNY | -30.68% |
| 2005 FY | 176.15 Million CNY | 20.54% |
| 2005 Q1 | 35.05 Million CNY | -8.08% |
| 2004 FY | 146.14 Million CNY | 28.84% |
| 2004 Q1 | 31.81 Million CNY | 21.12% |
| 2004 Q3 | 36.29 Million CNY | -9.04% |
| 2004 Q4 | 38.13 Million CNY | 5.07% |
| 2004 Q2 | 39.9 Million CNY | 25.44% |
| 2003 Q3 | 32.41 Million CNY | 3.35% |
| 2003 FY | 113.42 Million CNY | 5.72% |
| 2003 Q2 | 31.36 Million CNY | 34.12% |
| 2003 Q1 | 23.38 Million CNY | 0.14% |
| 2003 Q4 | 26.26 Million CNY | -18.98% |
| 2002 Q3 | 33.37 Million CNY | 25.2% |
| 2002 Q2 | 26.65 Million CNY | 11.53% |
| 2002 FY | 107.29 Million CNY | -5.85% |
| 2002 Q1 | 23.9 Million CNY | 0.0% |
| 2002 Q4 | 23.35 Million CNY | -30.04% |
| 2001 FY | 113.96 Million CNY | 16.5% |
| 2000 FY | 97.81 Million CNY | 19.37% |
| 1999 FY | 81.94 Million CNY | 25.93% |
| 1998 FY | 65.06 Million CNY | 0.0% |